• Western blot analysis of extracts of various cell lines, using CFDP1 antibody (STJ28247) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 90s.

Anti-CFDP1 antibody (1-299) (STJ28247)

SKU:
STJ28247

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CFDP1 (1-299) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CFDP1
Gene ID: 10428
Uniprot ID: CFDP1_HUMAN
Immunogen Region: 1-299
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-299 of human CFDP1 (NP_006315.1).
Immunogen Sequence: MEEFDSEDFSTSEEDEDYVP SGGEYSEDDVNELVKEDEVD GEEQTQKTQGKKRKAQSIPA RKRRQGGLSLEEEEEEDANS ESEGSSSEEEDDAAEQEKGI GSEDARKKKEDELWASFLND VGPKSKVPPSTQVKKGEETE ETSSSKLLVKAEELEKPKET EKVKITKVFDFAGEEVRVTK EVDATSKEAKSFFKQNEKEK PQANVPSALPSLPAGSGLKR SSGMSSLLGKIGAKKQKMS
Tissue Specificity Ubiquitous.
Post Translational Modifications Phosphorylated by CK2 (casein kinase II) in vitro.
Function May play a role during embryogenesis.
Protein Name Craniofacial Development Protein 1
Bucentaur
Cellular Localisation Chromosome
Centromere
Kinetochore
Alternative Antibody Names Anti-Craniofacial Development Protein 1 antibody
Anti-Bucentaur antibody
Anti-CFDP1 antibody
Anti-BCNT antibody
Anti-CENP-29 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance